Ubiquitous Nuclear Factors Bind Specifically to a 5′-Region Conserved in Carcinoembryonic Antigen-Related Genes by Rudert, Fritz et al.
Vol. 185, No. 3, 1992 BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 
June 30, 1992 Pages 893-901 
Ubiquitous Nuclear Factors Bind Specifically to a S-Region 
Conserved in Carcinoembryonic Antigen-Related Genes 
Fritz Rude&*, John Thompson and Wolfgang Zimmermann 
Institute of Immunobiology, University of Freiburg, D-7800 Freiburg, Germany 
0 Laboratoire de Genetique Moleculaire du CNRS, Unite 184 de Biologie 
Moleculaire du Genie Genetique de L’INSERM, Faculte de Medecine, 
11 Rue Humann, F-67085 Strasbourg CEDEX, France 
Received April 28, 1992 
Summary: We recently cloned members of the murine 
carcinoembryonic antigen (CEA) gene family, some of which are 
differentially expressed during placental development. By intra- and 
interspecies sequence comparisons, we identified an element in the 
putative promoter and/or 5’-nontranslated region which is conserved 
within all human and rodent CEA-related genes analyzed so far. Using 
gel retardation analysis and DNasel hypersensitive site mapping, we 
now show that ubiquitously expressed nuclear factors specifically bind 
to the conserved region derived from the mouse gene Cea-2 in vitro and 
probably also in vivo. Another DNasel hypersensitive site lies within or 
close to a simple sequence motif [(GGA), I located in the first intron of 
Cea-2. Such sequences have been reported to play a role in the 
regulation of certain genes. Therefore, this analysis has identified 
putative regulatory regions for Cea-2 and possibly CEA-related genes 
in general. 0 1992 Academic P?xSS. Inc. 
Carcinoembryonic antigen (CEA), a highly glycosylated protein, 
was originally described as an oncofetally expressed human tumor- 
specific antigen and was initially isolated from colon carcinomas (1,2). 
The later discovery of CEA in normal adult tissue and the existence of a 
large number of immunologically cross-reacting antigens has limited 
its potential use as a specific tumor marker (reviewed in 3). Through 
molecular cloning it has been shown during the last few years that CEA 
is a member of a large gene family comprising approximately 20 genes 
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in humans clustered on the long arm of chromosome 19 (reviewed in 4). 
This family can be subdivided into the CEA subgroup consisting of 
genes encoding CEA and the classical cross-reacting antigens and the 
PSG subgroup which encode the pregnancy specific glycoproteins (PSG) 
(see 4). Recently, members of the rodent CEA gene family have been 
discovered (58,ll)). The CEA gene families of rodents and humans both 
belong to the immunoglobulin supergene family (9-11) and have been 
shown to have evolved after mammalian radiation (12). Due to the 
apparently rapid evolution, a great sequence divergence and also 
striking structural dissimilarities have been observed between rodent 
and human CEA-related genes (7,8), making it impossible to assign 
individual counterparts in the respective species (12). However, by 
comparing their patterns of expression we have recently identified 
analogues of human PSG genes in both rat and mouse (7,8). The identical 
expression pattern of the structurally dissimilar human and rodent PSG 
genes makes it very likely that they have similar or identical 
transcriptional regulation mechanisms. Indeed, sequence comparisons 
have allowed the identification of a conserved region in the regulatory 
regions of genes of the CEA families (8). In this study, using the mouse 
PSG gene analogue Cea-2 (8), we demonstrate that ubiquitously 
expressed nuclear factors can bind to specific sequence elments of this 
conserved region in vitro and possibly also in viva. 
Materials and Methods 
Preparation of nuclear extracts : Placentae of staged mice (8) or other 
tissues of adult mice were used as a starting material. All steps were 
carried out on ice. The usual procedure to prepare nuclear extracts was 
as described (13) with the following modifications: Tissues were 
removed, immediately washed in 0.14 M NaCI, 10 mM TrisCI pH 8.0 and 
cut into pieces. Buffer I was supplemented with 0.1 % Triton X-100. 
After dialysis against buffer III, precipitates were removed by 
centrifugation, the supernatants were frozen in liquid N2 a n d 
afterwards directly used in gel retardation without further column 
chromatography. As an alternative method a hypotonic extraction 
procedure without detergent was used. Tissues were removed, 
transferred to PBS supplemented with 2 mM MgCl2, 5 mM KCI and 
minced followed by homogenization in 10 ml/g tissue in the same 
buffer. The cell suspension was centrifuged for 5 min at 375xg and the 
pellet lysed in a hypotonic buffer containing 10 mM HEPES pH 8.0, 2 mM 
MgCla, 5mM KCI, 0.5 mM spermidine (Sigma), 0.15 mM spermine (Sigma), 
0.5 mM phenyl-methyl-sulfonylfluoride (PMSF), 7 mM p- 
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mercaptoethanol, 0.25 pglml aprotinin (Sigma), 10 pg/ml leupeptin 
(Sigma) with15 strokes in a glass potter. Sucrose was slowly added to 
a final concentration of 0.3 M and the nuclei were centrifuged for 5 min 
at 9OOxg. The nuclei were washed with hypotonic buffer containing 0.3 
M sucrose and pelleted by centrifugation for 5 min at 800xg. The nuclei 
were then resuspended in 5 to 7 volumes of the pellet in elution buffer 
( 10 mM HEPES pH 8.0, 0.1 mM EDTA, 0.1 mM EGTA, 0.5 mM spermidine, 
0.15 mM spermine, 420 mM NaCI, 10 % glycerol, 0.5 mM PMSF, 7 mM f3- 
mercaptoethanol, 0.25 pg/ml aprotinin, 10 pg/ml leupeptin) and the 
nuclear proteins eluted for 30 min with occasional shaking. insoluble 
material was removed by centrifugation at 23000xg for 20 min and the 
supernatant frozen in liquid N2. 
Gel retardation assay : Binding reactions contained 40 mM KCI, 10 mM 
HEPES pH 7.6, 4 % Ficoll (Pharmacia), 1 mM EDTA, 1 mM DTT, 1 pg 
poly(dldC) (Pharmacia), 0.5 mM ATP (as cold competitor for free [32Pl- 
ATP), 5 pg nuclear extract, 0.2 pmole [s2Pl-ATP end-labeled double- 
stranded probe (specific activity 5 to 7.5 x 107 dpm/yg) and if 
required, a 250-, 300- or lOOO-fold molar excess of the respective 
double-stranded unlabeled competitor in a reaction volume of 25 ~1. 
Pipetting was done on ice followed by a 30 min incubation at room 
temperature. Three yl loading buffer were added and the complexes 
separated on 4 % nondenaturing polyacrylamide gels run in 0.5 x TBE at 
12 V/cm. Gels were vacuum dried and autoradiographed using X-ray 
film. 
DNasel hypersensitive site mapping : All steps were carried out on ice. 
Placentae were removed and homogenized in 30 ml/g tissue buffer B 
(0.15 mM spermine, 0.5 mM spermidine, 15 mM TrisCI pH 7.5, 60 mM 
KCI, 15 mM NaCI, 2 mM EDTA, 0.5 mM EGTA, 0.5 M sucrose) with 10 
strokes in a glass potter. Cells were centrifuged for 5 min at 15OOxg, 
resuspended in 20 ml buffer C (buffer B with 0.5 % Triton X-100) and 
lysed with 10 strokes in a glass potter. Nuclei were pelleted by 
centrifugation for 5 min at 15OOxg, washed in buffer D (buffer B with 
0.35 M sucrose) and the pellet frozen in liquid N2. 5 x 10s nuclei were 
resuspended in 2.25 ml buffer E (buffer B without sucrose and with 0.2 
mM EGTA, 1 mM PMSF) and aliquoted at 250 PI. These aliquots were 
digested with increasing amounts of DNasel (Worthington) in a total 
volume of 500 ~1 buffer E for 15 min on ice. Reactions were started by 
addition of 20 PI MgCl2 (100 mM) and stopped with 10 PI EDTA (0.5 M). 
The DNasel concentration was increased by doubling the units, starting 
with 32 units (Fig. 3, lane 3). Genomic DNA was prepared, digested with 
BamHl and 6.5 pg per lane were separated on a 1 % agarose gel. The DNA 
was transferred to Immobilon-NTM and hybridized with a [32Pl-labeled 
310 bp Stul/BamHI fragment from Cea-2 comprising most of the second 
exon (8). Filters were washed in 0.1 x SSPE/O.l YO SDS at 65 “C and 
autoradiographed at -80 “C using an intensifying screen. 
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Results and Discussion 
The strong interspecies conservation of a region lying in the 
vicinity of or at the transcriptional start sites of all CEA-related 
genes identified so far (8) prompted us to investigate whether this 
region might have a role in the regulation of these genes. We have 
chosen gel retardation assays to analyze whether nuclear factors can 
bind to the conserved region in vitro. As the mouse PSG analogues seem 
to be exclusively expressed in placenta, we prepared nuclear extracts 
from staged mouse placentae to look for such putative factors in this 
organ. As shown in Figure lA, a mobility shift of the labeled complex 
can be observed in a stage where the mouse PSG analogue Cea-2 is 
expressed (day 18) as well as in an inactive stage [(day 111, 81. The 
strongly labeled band seen at d18 and not at dll presumably represents 
an ATP-binding or a phosphorylated protein, because it is not visible 
after including cold ATP in the binding reaction. The complexes 
indicated in brackets seem to differ qualitatively at the different 
stages (Fig. 1A). The uppermost complex formed with day 11 placental 
extract (marked by an arrow) is apparently not present when day 18 
nuclear extract is used. 
To analyze which part of the conserved region is involved in DNA 
binding we cut the whole region down to individual subregions using 
double-stranded oligonucleotides. Interestingly, only the flanking 
regions A and D gave a retarded protein/DNA complex (Fig. 1B). The 
formation of such complexes could be drastically reduced when an 
excess of the respective unlabeled DNA was added as a competitor to 
the binding reactions (Fig. 1C). In Figure 1 D, a competition experiment 
using a high molar excess of either the specific competitors (A or D, 
respectively) or oligonucleotide B as a non-specific competitor is 
shown to rule out non-specific effects. Interestingly, it turned out that 
the two regions which bind nuclear factors are interchangeable to a 
certain extent in a competition assay, exhibiting cross-competition of 
each other (Fig. 1E). This makes it possible that related or even 
identical factors take part in complex formation with sequences 
present in probes A and D. In this context, it should be noted that 
regions A and D share an identical pentamer sequence which forms an 
inverted repeat (see Fig. 1 bottom). Whether such a motif represents a 
binding site for the putative regulatory factors remains to be shown. 
To examine whether the expression of such factors is exclusively 
restricted to placenta or can also be found in other tissues, we tested 
nuclear extracts from various adult mouse tissues as well as from the 
human colon adenocarcinoma cell line Lovo and the promyelocytic cell 
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Fia 1. Nuclear factors specifically bind to sequences in the conserved 
region of Cea-2. A, the conserved region generated by using [32Pl- 
labeled PCR primers A and D (see bottom) was used in the gel 
retardation assay. The arrow indicates the additional complex formed 
in the presence of dll placenta nuclear extract. The filled arrow head 
marks a non-specific complex which is absent when cold ATP is 
included in the binding reaction. 6, individual double-stranded 
oligonucleotides derived from the conserved region (A-D) were 
employed in the gel retardation assay to narrow down the binding 
region. C, specific competition of complex formation is shown using a 
250x molar excess of the indicated unlabeled oligonucleotides. D, the 
binding specificity of regions A and D is analyzed using a high molar 
excess (1000x) of either the specific competitors A or D, respectively 
or of oligonucleotide B as a nonspecific competitor. E , the ability of 
oligonucleotides A and D to reciprocally compete each other has been 
tested (300x). Specific complexes are indicated by brackets. The stages 
of the mouse placental nuclear extracts are indicated above the lanes. 
In E, nuclear extract from day 16 mouse placenta was used. At the 
bottom of the figure the sequence of the conserved region of Cea-2 (8) 
is shown together with the position of the oligonucleotides which have 
been used in gel retardation. The arrows above the sequence indicate an 
inverted repeat motif. 
line HL60. We detected shifts in the mobility of oligonucleotide D with 
all the extracts tested (Fig. 21, which argues that the factors are 
ubiquitously expressed. However, slight differences in the mobilities of 
such complexes may be due to the binding of related but not identical 
factors or the absence of certain factors in some extracts. Moreover, 
the presence of a nuclear factor capable of binding to this region at 
least in HL60 cells (and possibly also Love) indicates that these 
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D 
Fig. 2. Tissue distribution of the nuclear factors. A panel of nuclear 
extracts from different mouse tissues as well as two human cell lines 
was tested with probe D (see Fig. 1, bottom). Liver hypo. refers to a 
hypotonic extraction procedure for the nuclear proteins (see Materials 
and Methods). The specific complexes are bracketed. 
proteins are evolutionarily conserved. This would not be surprising for 
a putative transcription factor as numerous examples exist that such 
proteins are under highly selective pressure and are therefore very 
often strongly conserved throughout the animal kingdom (14). Indeed, 
Chinese hamster ovary cells which were stably transfected with a 
cosmid clone containing the complete human CEA gene correctly 
expressed CEA (15) confirming that rodent trans-acting factors 
interact with the regulatory sequences of the CEA gene. 
The location of the conserved region in the middle of the 5’- 
nontranslated region of Cea-2 also makes the involvement in 
posttranscriptional regulation possible, as has been shown for the TAR 
region of HIV1 mRNA (16). Although we found no mobility changes when 
single-stranded versions of the probes A to D were used (data not 
shown), we cannot firmly rule out a contribution of this region at the 
posttranscriptional level. 
Based on these in vitro studies we looked for in vivo protein/DNA 
interactions at the conserved region of Cea-2. To achieve this, we 
digested chromatin from dll placental nuclei (a stage when no Cea-2 
mRNA can be detected) with increasing amounts of DNasel to look for 
DNasel hypersensitive sites in the putative regulatory regions of the 
Cea-2 gene which would be indicative of such interactions. This 
analysis indicates the presence of a hypersensitive site within or near 
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Fig. 3. Mapping of DNasel hypersensitive sites in the putative control 
regions of Cea-2. Nuclei, isolated from day 11 mouse placenta were 
digested with increasing amounts of DNasel (lanes 3-8). No DNase was 
added in lanes 1 and 2. The DNA was extracted from the nuclei and 
digested with BamHl to completion. After transfer of the DNA the 
membrane was hybridized with a genomic probe derived from Cea-2. In 
the lower part of the Figure, a physical map of the genomic BamHl 
fragment of Cea-2 which is detected by the probe is shown. The 
positions of DNasel hypersensitive sites (HSS) are indicated with 
arrows. The thin horizontal arrow indicates the transcriptional start of 
Cea-2. The filled boxes represent polypyrimidine [(CCTT),] or 
polypurine [(AGG),, unpublished] simple sequences, respectively. Open 
boxes represent exons. L, leader exon; N, N-terminal exon; B, BamHI. 
to the conserved region (HSS2 in Fig. 3) which correlates well with the 
in vitro data (see Fig. 1). It remains to be shown whether this in viva 
interaction reflects a repressor activity present at a stage when Cea-2 
is not transcribed or the inactive state of this gene is caused by the 
absence of additional activating factors required at this site. In 
addition, another hypersensitive site (HSSl in Fig. 3) has been found in 
the first intron of Cea-2 which apparently coincides with a (GGA), 
simple sequence (unpublished). Simple sequences have been reported for 
a number of other rodent (7,8,11) and human (17,18) PSG genes. Similar 
copies of such sequences are also found in other types of genes and 
have been implicated in a variety of biological functions, such as gene 
regulation (19) or as hot spots for recombination (20). Whether these 
sequences are involved in the regulation of the mouse PSG analogue 
Cea-2 and possibly other PSG genes remains to be elucidated. The 
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present study, however, already gives some insight into putative 
control regions for the regulation of expression of CEA-related genes 
for future functional analysis. 
It will be of particular interest to elucidate the regulatory 
potential of the conserved region and of the nuclear proteins which bind 
to it, especially in view of the lack of typical promoter sequences 
(TATA-box, CAAT-box) in CEA-related genes (8). The high sequence 
conservation of the region investigated here argues for a common 
regulatory element such as a minimal promoter or an “initiator” (21). 
However, a potential involvement in spatiotemporal transcriptional 
regulation via tissue-specific factors is not excluded. The latter 
possibility is strengthened by the fact that a region of the human CEA 
gene comprising 314 nucleotides upstream of the transcriptional start 
and therefore including the whole conserved region analyzed here has 
been shown to convey cell-specific regulation in transient transfection 
experiments (22). Such behavior, however, was not found for the 
respective, highly similar region of the non-specific cross-reacting 
antigen (NCA) gene, a closely related member of the human CEA- 
subgroup. In this context, it might be interesting to note that a number 
of nucleotide sequence differences are observed between CEA and NCA 
in this conserved region. Future functional studies on the promoter 
activity should shed some light on the regulation of the restricted 
spatiotemporal expression of PSG genes in rodents and human. 
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